Effects of race on albuminuria and risk of cardiovascular and kidney disease

References

• Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int.70(7), 1214–1222 (2006).
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA289(19), 2560–2572 (2003).
   PubMed Web of Science ®Google Scholar
• de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J. Am. Soc. Nephrol.17(8), 2100–2105 (2006).
   PubMed Web of Science ®Google Scholar
• Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation106(14), 1777–1782 (2002).
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann. Intern. Med.139(2), 137–147 (2003).
   PubMed Web of Science ®Google Scholar
• Gansevoort RT, Brinkman J, Bakker SJ, de Jong PE, de Zeeuw D. Evaluation of measures of urinary albumin excretion. Am. J. Epidemiol.164(8), 725–727 (2006).
   PubMed Web of Science ®Google Scholar
• Forman JP, Brenner BM. ‘Hypertension’ and ‘microalbuminuria’: the bell tolls for thee. Kidney Int.69(1), 22–28 (2006).
   PubMed Web of Science ®Google Scholar
• Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J. Am. Soc. Nephrol.19(10), 1983–1988 (2008).
   PubMed Web of Science ®Google Scholar
• Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet375(9731), 2073–2081 (2010).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Kopp JB, Langefeld CD et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol.21(9), 1422–1426 (2010).
   PubMed Web of Science ®Google Scholar
• Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am. J. Kidney Dis.39(3), 445–459 (2002).
   PubMed Web of Science ®Google Scholar
• Young BA, Katon WJ, Von KM et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J. Am. Soc. Nephrol.16(1), 219–228 (2005).
   PubMed Web of Science ®Google Scholar
• Bryson CL, Ross HJ, Boyko EJ, Young BA. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am. J. Kidney Dis.48(5), 720–726 (2006).
   PubMed Web of Science ®Google Scholar
• Hsu CC, Brancati FL, Astor BC et al. Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study. J. Hypertens.27(2), 397–409 (2009).
   PubMed Web of Science ®Google Scholar
• Murtaugh MA, Jacobs DR Jr, Yu X, Gross MD, Steffes M. Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. Am. J. Epidemiol.158(7), 676–686 (2003).
   PubMed Web of Science ®Google Scholar
• Ogunniyi MO, Croft JB, Greenlund KJ, Giles WH, Mensah GA. Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999–2006. Am. J. Hypertens.23(8), 859–864 (2010).
   PubMed Web of Science ®Google Scholar
• Hoq S, Chen W, Srinivasan SR, Berenson GS. Childhood blood pressure predicts adult microalbuminuria in African Americans, but not in whites: the Bogalusa Heart Study. Am. J. Hypertens.15(12), 1036–1041 (2002).
   PubMed Web of Science ®Google Scholar
• Detrano R, Guerci AD, Carr JJ et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med.358(13), 1336–1345 (2008).
   PubMed Web of Science ®Google Scholar
• Bild DE, Detrano R, Peterson D et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation111(10), 1313–1320 (2005).
   PubMed Web of Science ®Google Scholar
• Budoff MJ, Nasir K, Mao S et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis187(2), 343–350 (2006).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Hsu FC, Langefeld CD et al. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Diabetologia48(12), 2511–2518 (2005).
   PubMed Web of Science ®Google Scholar
• Divers J, Wagenknecht LE, Bowden DW et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-Diabetes Heart Study. Diabetes Care33(1), 131–138 (2010).
   PubMed Web of Science ®Google Scholar
• Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care26(8), 2392–2399 (2003).
   PubMed Web of Science ®Google Scholar
• Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA287(19), 2519–2527 (2002).
   PubMed Web of Science ®Google Scholar
• Wassel CL, Pankow JS, Peralta CA, Choudhry S, Seldin MF, Arnett DK. Genetic ancestry is associated with subclinical cardiovascular disease in African–Americans and Hispanics from the multi-ethnic study of atherosclerosis. Circ. Cardiovasc. Genet.2(6), 629–636 (2009).
   PubMed Web of Science ®Google Scholar
• Knopman DS, Mosley J, Bailey KR, Jack J, Schwartz GL, Turner ST. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J. Neuro. Sci.271(1–2), 53–60 (2008).
   PubMed Web of Science ®Google Scholar
• Astor BC, Hallan SI, Miller ER III, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am. J. Epidemiol.167(10), 1226–1234 (2008).
   PubMed Web of Science ®Google Scholar
• Yuyun MF, Adler AI, Wareham NJ. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr. Opin. Nephrol. Hypertens.14(3), 271–276 (2005).
   PubMed Web of Science ®Google Scholar
• Ochodnicky P, Henning RH, van Dokkum RP, de Zeeuw D. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. J. Cardiovasc. Pharmacol.47(Suppl. 2), S151–S162 (2006).
   Google Scholar
• Peralta CA, Li Y, Wassel C et al. Differences in albuminuria between Hispanics and whites: an evaluation by genetic ancestry and country of origin: the multi-ethnic study of atherosclerosis. Circ. Cardiovasc. Genet.3(3), 240–247 (2010).
   PubMed Web of Science ®Google Scholar
• Iyengar SK, Abboud HE, Goddard KA et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes56(6), 1577–1585 (2007).
   PubMed Web of Science ®Google Scholar
• Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science329(5993), 841–845 (2010).
   PubMed Web of Science ®Google Scholar
• Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet.128(3), 345–350 (2010).
   PubMed Web of Science ®Google Scholar
• Kopp JB, Smith MW, Nelson GW et al.MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet.40(10), 1175–1184 (2008).
   PubMed Web of Science ®Google Scholar
• Kao WH, Klag MJ, Meoni LA et al.MYH9 is associated with nondiabetic end-stage renal disease in African–Americans. Nat. Genet.40(10), 1185–1192 (2008).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Hicks PJ, Bostrom MA et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int.75(7), 736–745 (2009).
   PubMed Web of Science ®Google Scholar
• Bostrom MA, Freedman BI. The spectrum of MYH9-associated nephropathy. Clin J. Am. Soc. Nephrol.5, 1107–1113 (2010).
   PubMed Web of Science ®Google Scholar